Badger Meter is a Milwaukee-based provider of flow measurement, water quality, and control technologies, and a leading player in the ongoing digital transformation of the water sector. Its third quarter 2026 results matter because they arrive after a choppy first half, during which uneven timing of utility smart-meter projects pressured sales. Investors are closely watching whether the company's shift toward higher-margin software, ultrasonic meters, and "beyond the meter" solutions can offset near-term revenue softness. The report also offers a read on electronic component cost pressures tied to the broader artificial intelligence and data-center build-out, which have squeezed input costs across the industrial technology landscape. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, Badger Meter posted net sales of $235.9 million, essentially flat versus $235.7 million in the prior-year period and slightly below consensus expectations near $240 million. Diluted EPS rose 4% to $1.24, topping analyst estimates of roughly $1.22 to $1.23.
Profitability was the quarter's highlight. Operating earnings increased 4% to $47.7 million, lifting operating margin 60 basis points to 20.2%. Gross margin expanded 120 basis points to 41.9%, driven by a favorable mix shift toward ultrasonic meters and growing software-as-a-service revenue. Excluding the UDlive acquisition completed in May 2026, base gross margin reached 42.1%, the top of the company's normalized range.
Net earnings were $35.9 million, compared with $35.1 million a year earlier. Free cash flow was $40.3 million, down from $48.2 million, reflecting higher cash taxes. Flow instrumentation sales rose 2% year over year, supported by water applications and emerging data-center demand.
Shares of BMI rose roughly 7% in the session following the report, a notable move on a day when the broader Nasdaq traded lower. The rally signaled that investors chose to look past the modest revenue miss and focus instead on margin expansion, improving sequential momentum, and management's constructive commentary on the fourth quarter and 2027. The company said base sales, which exclude UDlive, rose 5% sequentially from the second quarter as previously awarded utility projects began to ramp, an inflection point after a difficult first half. The 10% dividend increase and continued share repurchases reinforced confidence in cash generation and shareholder returns.
Management expects both sequential and year-over-year base sales growth in the fourth quarter of 2026, even with fewer operating days due to the holiday calendar, and anticipates sustaining that momentum into 2027. For the full year, organic revenue is now expected to decline in the low single digits, an improvement from earlier, more cautious guidance.
Several factors will shape the quarters ahead. First, the pacing of large utility smart-meter projects remains inherently uneven, and investors should watch whether awarded contracts convert to shipments on schedule. Second, electronic component costs and availability, driven by artificial intelligence and data-center demand, continue to pressure materials; the company has so far offset these through pricing and product mix, but the challenge persists.
Third, the structural shift toward higher-margin software and ultrasonic meters is a key margin lever, with management expecting gross margin to remain within its 39% to 42% range. Finally, the integration of recent acquisitions such as UDlive and SmartCover, along with the launch of the OneNetwork software platform, will be important indicators of the company's ability to expand beyond traditional metering. Investors will also monitor free cash flow conversion, which management targets at above 100% of net earnings. From what I see, these elements point to a company navigating near-term headwinds while positioning for longer-term gains.
I often turn to Tickeron's AI Daily Buy/Sell Signals when evaluating how earnings reports like this one might influence near-term trading patterns. It provides a quick way to cross-check signals across similar names in the industrial and water technology space without having to build extensive custom screens from scratch. This helps me stay focused on the fundamentals while adding another layer of data-driven context to the analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BMI saw its Momentum Indicator move below the 0 level on November 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 97 similar instances where the indicator turned negative. In 62 of the 97 cases, the stock moved further down in the following days. The odds of a decline are at 64%.
The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 19 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 29 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 70 cases where BMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
The 50-day moving average for BMI moved above the 200-day moving average on November 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +3.67% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 182 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 130 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 69 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments